Pharmacogenomics research is yielding molecular diagnostic tools that can be used to optimize the selection of medications and their doses for individual patients. Given the narrow therapeutic index of most anticancer agents and the serious consequences of undertreatment, cancer chemotherapy is a compelling therapeutic area for translation of pharmacogenomics to the clinic. This review addresses how inherited (germline) and acquired (somatic) sources of genome variability can alter the toxicity or efficacy of cancer chemotherapy.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3646359 | PMC |
| http://dx.doi.org/10.1038/clpt.2011.126 | DOI Listing |
Publication Analysis
Top Keywords
cancer chemotherapy
8
cancer pharmacogenomics
4
pharmacogenomics pharmacogenomics
4
pharmacogenomics yielding
4
yielding molecular
4
molecular diagnostic
4
diagnostic tools
4
tools optimize
4
optimize selection
4
selection medications
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!